Skip to content

Clinical observation of paclitaxel/ cisplatin concomitant chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma

Clinical observation of paclitaxel/ cisplatin concomitant chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-11001927
Enrollment
Unknown
Registered
2011-12-22
Start date
2009-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

locoregionally advanced nasopharyngeal carcinoma

Interventions

A:chemoradiotherapy (1)

Sponsors

The Affiliated Hospital of Guangdong Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The pathological and histological experimental for nasopharyngeal carcinoma of the horns; 2. The clinical stages III-IV a (2008 stage) first visit with NPC; 3. Age 18-65 years old; 4. No blood diseases, before the group of white blood cells more than equal to 4.0*10^9/L, is less than or equal to 10*10^9/L, is equal or greater than 100*10^9 platelet/L, hemoglobin is equal or greater than 80 g/L; 5. Liver function (ALT, AST is less than or equal to limit *1.5 times of normal), kidney: creatinine clearance is equal or greater than 60 ml/min; 6. KPS score more than equal to 70; 7. Already informed agreement signed.

Exclusion criteria

Exclusion criteria: 1. The pathological and histological for Angle of cancer; 2. Older than 65 years or less than 18 years; 3. Serious heart impaired kidney function; 4. Have other malignant tumors history; 5. Once a radiation and chemotherapy; 6. Pregnant women or feeding period; 7. Mental disorders or can't articulate response to treatment.

Design outcomes

Primary

MeasureTime frame
The original tumor complete remission rate and effect;Lymph node complete response rate and efficiency;

Contacts

Public ContactYu Zhong-hua
zhonghua_yu@126.com+86 13702882898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026